Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Donna Schmoll"'
Autor:
Raymond G. Hoffmann, Gregory J. Harrington, B. O. Khatri, Donna Schmoll, Michael P. McQuillen
Publikováno v:
Neurology. 41(3)
Plasma exchange (PE) was shown in a previous double-blind randomized controlled study to confer significant additional benefit at 1 year upon patients with chronic progressive multiple sclerosis (CPMS) treated with immunosuppressive drug therapy (ISD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c953f02a211fdd4bd202bfc345e1462
https://pubmed.ncbi.nlm.nih.gov/2006010
https://pubmed.ncbi.nlm.nih.gov/2006010
Autor:
Donna Schmoll, Bhupendra O. Khatri, Raymond G. Hoffmann, Gregory J. Harrington, Michale P. McQuillen
Publikováno v:
Neurology. 35:614-614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::862a311c5629b8e7c1606b8c4a05f3ac
https://doi.org/10.1212/wnl.35.4.614
https://doi.org/10.1212/wnl.35.4.614
Autor:
Gregory J. Harrington, Michael P. McQuillen, Donna Schmoll, Bhupendra O. Khatri, Raymond G. Hoffmann
Publikováno v:
Neurology. 35:312-312
Fifty-four patients with chronic progressive multiple sclerosis received prednisone plus oral low-dose cyclophosphamide and either true plasmapheresis (PP) or "sham" PP weekly for 20 weeks in a double-blind controlled study. Immunosuppressive drug th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3992b99f3b70bcfa030692e04e86bc
https://doi.org/10.1212/wnl.35.3.312
https://doi.org/10.1212/wnl.35.3.312